Shoulder-surfing resistant PIN-entry method Tekijä Shudi CHEN, Youwen ZHU

Hae kokoteksti

Group Authentication Key Agreement Protocol Based on Certificateless Cryptography in UAV Network Tekijä Yuecheng WANG, Youwen ZHU, Zhiqiang ZHANG

Hae kokoteksti

One-time password authentication for one-way communication without re-registration Tekijä Qianqian LU, Youwen ZHU, Yan JIANG

Hae kokoteksti

TAS-102 with or without bevacizumab treatment for patients with metastatic colorectal cancer: a multi-country cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Hong Zhu

Hae kokoteksti

The cost-effectiveness analysis of maintenance olaparib plus Bevacizumab in patients with advanced ovarian cancer: based on the final survival results from PAOLA-1 trial Tekijä Youwen Zhu, Kun Liu, Hui Cao, Hong Zhu

Hae kokoteksti

Immunotherapy or targeted therapy as the first-line strategies for unresectable hepatocellular carcinoma: A network meta-analysis and cost-effectiveness analysis Tekijä Kun Liu, Youwen Zhu, Hong Zhu, Hong Zhu

Hae kokoteksti

Immune checkpoint inhibitors plus chemotherapy for HER2-negative advanced gastric/gastroesophageal junction cancer: a cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Hong Zhu, Haijun Wu

Hae kokoteksti

Vascular Endothelial Growth Factor Receptor Inhibitors in Chinese Patients With Advanced Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Network Meta-Analysis and Co... Tekijä Youwen Zhu, Kun Liu, Kailing Wang, Libo Peng

Hae kokoteksti

Combination tumor‐treating fields treatment for patients with metastatic non‐small cell lung cancer: A cost‐effectiveness analysis Tekijä Kun Liu, Youwen Zhu, Hong Zhu, Manting Zeng

Hae kokoteksti

Trastuzumab deruxtecan versus chemotherapy for patients with HER2-low advanced breast cancer: A US-based cost-effectiveness analysis Tekijä Youwen Zhu, Youwen Zhu, Kun Liu, Kun Liu, Xiaolu Zhu, Xiaolu Zhu, Qun Qin, Qun Qin, Hong Zhu, Hong Zhu

Hae kokoteksti

An efficient hash-based authenticated key agreement scheme for multi-server architecture resilient to key compromise impersonation Tekijä Inam ul haq, Jian Wang, Youwen Zhu, Saad Maqbool

Hae kokoteksti

Comparative efficacy and safety of novel immuno-chemotherapy for extensive-stage small-cell lung cancer: a network meta-analysis of randomized controlled trial Tekijä Youwen Zhu, Kun Liu, Hong Zhu, Hui Cao, Yangying Zhou

Hae kokoteksti

Adverse events of biologic or small molecule therapies in clinical trials for inflammatory bowel disease: A systematic review and meta-analysis Tekijä Kailing Wang, Youwen Zhu, Kun Liu, Hong Zhu, Miao Ouyang

Hae kokoteksti

Metaverse: Security and Privacy Concerns Tekijä Zhongyun Hua, Rushi Lan, Yushu Zhang, Ruoyu Zhao, Youwen Zhu

Hae kokoteksti

Trastuzumab deruxtecan versus trastuzumab emtansine for patients with human epidermal growth factor receptor 2-positive metastatic breast cancer: A cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Min Wang, Kailing Wang, Hong Zhu

Hae kokoteksti

Enfortumab vedotin plus pembrolizumab for previously untreated locally advanced or metastatic urothelial carcinoma: a cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Hong Zhu, Shan Li, Dan Yuan

Hae kokoteksti

BPPIR: Blockchain-assisted privacy-preserving similarity image retrieval over multiple clouds Tekijä Miao Tian, Yushu Zhang, Youwen Zhu, Wei Wang, Qihui Wu, Yong Xiang

Hae kokoteksti

First-line Immuno-chemotherapy for extensive-stage small-cell lung cancer: A network meta-analysis and cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Qiuping Yang, Manting Zeng, Manting Zeng, Libo Peng

Hae kokoteksti

Chemo-Immunotherapy Regimes for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Network Meta-Analysis and Cost-Effectiveness Analysis Tekijä Youwen Zhu, Kun Liu, Dong Ding, Kailing Wang, Xiaoting Liu, Xiao Tan

Hae kokoteksti

Serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis Tekijä Youwen Zhu, Kun Liu, Qun Qin, Qun Qin, Hong Zhu, Hong Zhu

Hae kokoteksti